Abstract:
The present invention provides a high-purity acid-form sophorolipid (SL)-containing composition characterized by substantially not containing acetic acid. The high-purity acid-form SL-containing composition can be produced, for example, by the following method: (i) adjusting the pH of a partially purified acid-form SL-containing composition to an acidic range; and (ii-a) subjecting an acidified partially purified acid-form SL-containing composition obtained in step (i) to chromatography to acquire a fraction containing an acid-form SL, or (ii-b) leaving the acidified partially purified acid-form SL-containing composition obtained in step (i) to stand under a low-temperature condition to acquire a resulting gelled object.
Abstract:
The present invention provides an alcohol-based rub-in hand sanitizer composition with a good feel in use. The alcohol-based rub-in hand sanitizer composition of the present invention is a liquid or viscous composition having a pH of 5.5 to 7.5 and comprising the following components: (A) a lower alcohol: 50 to 90 vol %; (B) at least one polyhydric alcohol selected from the group consisting of glycerin, 1,3-butylene glycol, and propylene glycol: 0.01 to 1.0 mass %; (C) isopropyl myristate and a glycerin fatty acid ester: each 0.01 to 0.12 mass %; and (D) water.
Abstract:
The invention relates to an ultrafine bubble (UFB) generator and a method for generating UFB. The invention also provides an ultrafine bubble-containing liquid and a production method of the liquid. An ultrafine bubble generator is prepared by combining (A) a sophorolipid containing acidic sophorolipid and lactonic sophorolipid in a ratio (mass ratio) of 78:22 to 100:0, (B) a free fatty acid or salt thereof, and (C) a gas generation component.
Abstract:
The invention provides a percarboxylic acid concentration-determining device capable of determining the concentration of percarboxylic acid contained in an aqueous solution for chemical sterilization or disinfection that contains a percarboxylic acid as an active ingredient; and an indicator solution for use in preparing the device. The indicator solution contains a starch, an iodide, a thiosulfate, a water-soluble organic solvent, and water, with the starch, the iodide, the thiosulfate, and the water-soluble organic solvent being present in the following proportions, based on the total amount taken as 100 mass %: (a) starch: 0.01 to 5 mass %; (b) iodide: 0.01 to 5 mass %; (c) thiosulfate: 0.01 to 10 mass %; and (d) water-soluble organic solvent: 0.1 to 40 mass %, wherein the total amount of (a), (b), and (c) is greater than 0.6 mass %.
Abstract:
The present invention relates to a reagent kit for detecting biofilm in test tissue, the reagent kit comprising: (a) a pretreatment liquid comprising at least one surfactant selected, from the group consisting of nonionic surfactants, amphoteric surfactants, and cationic surfactants, (b) a staining liquid comprising a dye, and (c) a decolorizing liquid comprising at least one surfactant selected from the group consisting of nonionic surfactants, amphoteric surfactants, and cationic surfactants; wherein after a membrane is brought into contact with the test tissue and released from contact, the pretreatment liquid (a), the staining liquid (b), and the decolorizing liquid (c) are brought into contact with the contact surface of the membrane in this order.
Abstract:
A problem to be solved by the present invention is to provide a method of assisting diagnosis of the health condition of a subject by correcting variation in an amount of a collected disease marker, which is caused by variation in the skin barrier function of the subject, and acquiring information reflecting the health condition of the subject accurately, and to solve the problem, the present invention provides a method of assisting diagnosis of a disease in a subject using a disease marker and a reference marker, the method including: applying, to a skin surface of the subject, a sheet capable of generating an attractive force due to electrostatic interaction between the sheet and each of the disease and reference markers; detaching the sheet from the skin surface; measuring the amount of each of the disease and reference markers that are attached to the sheet; and acquiring information on the disease in the subject based on a value obtained by correcting the measured amount of the disease marker with the measured amount of the reference marker, wherein the reference marker is annexin A2.
Abstract:
Provided is a system for supplying a liquid (such as an irritative chemical solution) safely. This liquid supplying system comprises: (a) a means that creates a negative pressure in a treatment chamber by driving a first depressurizing means and depressurizing the treatment chamber; (b) a means that introduces the negative pressure of the treatment chamber to a measurement chamber; (c) a means that maintains the negative pressure introduced to the measurement chamber; (d) a means that sucks a liquid from a container into the measurement chamber by employing the negative pressure of the measurement chamber; and (e) a means that sucks the liquid of the measurement chamber into the treatment chamber by employing a vacuum in the treatment chamber.
Abstract:
A sterilization system comprises a reaction container configured to receive a sterilization object and sterilize the object; means for supplying peracetic acid as an sterilization agent into the reaction container, the peracid agent including at least peracetic acid; means for reducing a pressure in the reaction container; means for ventilating the reaction container; and means for generating plasma at a first predetermined portion for receiving the sterilization object in the reaction container and a second predetermined portion of a fluid passage from a neighborhood of the first predetermined portion to an exterior of the container. The pressure reducing means and the plasma generating means are controlled so that the plasma is maintained at the predetermined portions in a process during which the pressure in the reaction container is reduced.
Abstract:
The present invention provides an orally administered composition comprising a sophorolipid, a physiologically active substance, and an oil or fat, wherein the physiologically active substance exhibits an improved bioavailability.
Abstract:
According to the present invention, a sterilant can be injected into a container without residual water on an object to be sterilized. The method includes decreasing a pressure in the container to a pressure higher than the triple point pressure at which water freezes. The method further includes comparing an actual time required for decreasing the pressure and a reference time, or comparing an actual rate of pressure increase and a reference rate to detect residual water on the object. If the residual water is detected, the pressure in the container is increased to the atmospheric pressure or the quasi-atmospheric pressure and the object is heated, and then the pressure is decreased to drain the residual water through the decompression boiling. The step of draining the residual water is repeatedly performed until no residual water is detected on the object and subsequently the sterilant is injected into the container.